Bank Julius Baer & Co. Ltd Zurich raised its position in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 8.2% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 2,506 shares of the company’s stock after purchasing an additional 190 shares during the quarter. Bank Julius Baer & Co. Ltd Zurich’s holdings in DocuSign were worth $249,000 as of its most recent SEC filing.
A number of other large investors also recently bought and sold shares of the company. Itau Unibanco Holding S.A. bought a new position in shares of DocuSign in the 3rd quarter worth about $28,000. Kestra Investment Management LLC acquired a new stake in DocuSign during the fourth quarter worth about $30,000. Brooklyn Investment Group bought a new position in DocuSign in the third quarter worth about $33,000. Modus Advisors LLC acquired a new position in DocuSign in the fourth quarter valued at approximately $36,000. Finally, First Horizon Advisors Inc. grew its holdings in shares of DocuSign by 102.6% during the fourth quarter. First Horizon Advisors Inc. now owns 397 shares of the company’s stock valued at $36,000 after purchasing an additional 201 shares during the last quarter. Institutional investors own 77.64% of the company’s stock.
Analyst Ratings Changes
DOCU has been the topic of several recent research reports. Jefferies Financial Group raised their price target on DocuSign from $80.00 to $95.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Piper Sandler raised their target price on DocuSign from $60.00 to $90.00 and gave the company a “neutral” rating in a research note on Friday, December 6th. JPMorgan Chase & Co. upgraded shares of DocuSign from an “underweight” rating to a “neutral” rating and upped their price target for the stock from $70.00 to $75.00 in a research report on Monday. Morgan Stanley increased their price objective on shares of DocuSign from $62.00 to $97.00 and gave the stock an “equal weight” rating in a report on Friday, December 6th. Finally, HSBC reissued a “reduce” rating on shares of DocuSign in a research note on Friday, December 6th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, DocuSign presently has a consensus rating of “Hold” and an average price target of $92.91.
Insiders Place Their Bets
In other DocuSign news, CFO Blake Jeffrey Grayson sold 8,000 shares of the business’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $86.90, for a total value of $695,200.00. Following the sale, the chief financial officer now directly owns 77,851 shares in the company, valued at approximately $6,765,251.90. The trade was a 9.32 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Robert Chatwani sold 14,800 shares of the firm’s stock in a transaction dated Wednesday, December 18th. The shares were sold at an average price of $97.76, for a total transaction of $1,446,848.00. Following the transaction, the insider now owns 73,414 shares of the company’s stock, valued at approximately $7,176,952.64. This trade represents a 16.78 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 104,422 shares of company stock worth $9,665,394 over the last ninety days. Company insiders own 1.66% of the company’s stock.
DocuSign Trading Down 2.5 %
Shares of NASDAQ:DOCU opened at $77.86 on Tuesday. The company has a 50 day moving average of $88.78 and a 200-day moving average of $78.90. The firm has a market cap of $15.73 billion, a P/E ratio of 16.05, a P/E/G ratio of 6.94 and a beta of 1.02. DocuSign, Inc. has a twelve month low of $48.70 and a twelve month high of $107.86.
DocuSign Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
See Also
- Five stocks we like better than DocuSign
- What Investors Need to Know to Beat the Market
- How to Protect Your Portfolio When Inflation Is Rising
- What is a Bond Market Holiday? How to Invest and Trade
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.